XML 42 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Compensation
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
The Company typically grants equity awards annually at its regularly scheduled first quarter meeting of the Board of Directors based on the recommendation from the Compensation Committee.

The Company’s policy is to recognize compensation cost on a straight-line basis, assuming forfeitures, over the requisite service period for the entire award. Classification of stock compensation cost within the Condensed Consolidated Statements of Income is consistent with the classification of cash compensation for the same employees.
Stock Options

Stock options granted under the Company’s plans are generally non-qualified and are granted with an exercise price equal to the market price of the Company’s stock on the date of grant. The fair value of each option grant was estimated on the date of the grant using the Black Scholes valuation model. Stock options generally vest ratably over four years, with vesting beginning one year from the date of grant, and generally expire 10 years from the date of grant. The service period for certain retiree eligible participants is accelerated. Weighted average stock option fair values and assumptions for the periods presented are disclosed below.

 Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
Weighted average fair value of grants$56.47$52.91$60.49$41.90
Dividend yield1.20%1.16%1.07%1.14%
Volatility26.78%25.99%27.17%25.16%
Risk-free interest rate
4.26%
3.35%
4.12%
1.87%
Expected life (in years)4.504.904.504.90

Total compensation cost for stock options is recorded in the Condensed Consolidated Statements of Income as follows:

 Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
Cost of sales$0.1 $0.1 $0.5 $0.4 
Selling, general and administrative expenses(1)
1.0 0.7 8.2 6.6 
Total expense before income taxes1.1 0.8 8.7 7.0 
Income tax benefit(0.2)(0.1)(0.8)(0.6)
Total expense after income taxes$0.9 $0.7 $7.9 $6.4 

(1) The three months ended September 30, 2023 include $0.4 million of higher expense due to timing of accelerated stock compensation costs for retiree eligible participants, net of $0.2 million of executive forfeitures compared with the same period in 2022. The nine months ended September 30, 2023 include $1.5 million of higher expense compared with the same period in 2022 as it relates to the timing of accelerated stock compensation costs for retiree eligible participants.

A summary of the Company’s stock option activity as of September 30, 2023 and changes during the nine months ended September 30, 2023 are presented in the following table:
Stock OptionsSharesWeighted
Average
Price
Weighted-Average
Remaining
Contractual Term
Aggregate
Intrinsic
Value
(Dollars in millions except weighted average price)
Outstanding at January 1, 20231,015,572 $161.45 6.94$67.9 
Granted225,115 224.90 
Exercised(87,217)143.37 
Forfeited(71,833)200.60 
Outstanding at September 30, 20231,081,637 $173.52 6.82$40.9 
Vested and expected to vest as of September 30, 20231,048,823 $172.37 6.76$40.7 
Exercisable at September 30, 2023595,028 $148.02 5.44$35.8 

As of September 30, 2023, there was $10.0 million of total unrecognized compensation cost related to stock options that is expected to be recognized over a weighted-average period of 1.5 years.
Restricted Stock

Restricted stock awards generally cliff vest after three years for employees and non-employee directors. The service period for certain retiree eligible participants is accelerated. Unvested restricted stock carries dividend and voting rights and the sale of the shares is restricted prior to the date of vesting. Dividends are paid on restricted stock awards and their fair value is equal to the market price of the Company’s stock at the date of the grant. A summary of the Company’s restricted stock activity as of September 30, 2023 and changes during the nine months ended September 30, 2023 are presented in the following table:

Restricted StockSharesWeighted-Average
Grant Date Fair
Value
Unvested at January 1, 2023104,382 $179.45 
Granted41,075 219.72 
Vested(22,992)173.91 
Forfeited(12,220)201.97 
Unvested at September 30, 2023110,245 $193.11 

Total compensation cost for restricted stock is recorded in the Condensed Consolidated Statements of Income as follows:

 Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
Cost of sales$0.1 $— $0.4 $0.2 
Selling, general and administrative expenses(1)
1.0 2.2 4.0 5.4 
Total expense before income taxes1.1 2.2 4.4 5.6 
Income tax benefit(0.2)(0.4)(0.9)(1.0)
Total expense after income taxes$0.9 $1.8 $3.5 $4.6 

(1) The three and nine months ended September 30, 2023 include $1.1 million and $0.6 million, respectively, of lower expense due to timing of accelerated stock compensation costs for retiree eligible participants compared with the same period in 2022.

As of September 30, 2023, there was $7.3 million of total unrecognized compensation cost related to restricted stock that is expected to be recognized over a weighted-average period of 1.1 years.

Cash-Settled Restricted Stock

The Company also maintains a cash-settled share-based compensation plan for certain employees. Cash-settled restricted stock awards generally cliff vest after three years. The service period for certain retiree eligible participants is accelerated. Cash-settled restricted stock awards are recorded at fair value on a quarterly basis using the market price of the Company’s stock on the last day of the quarter. Dividend equivalents are paid on certain cash-settled restricted stock awards. A summary of the Company’s unvested cash-settled restricted stock activity as of September 30, 2023 and changes during the nine months ended September 30, 2023 are presented in the following table:
Cash-Settled Restricted StockSharesWeighted-Average
Fair Value
Unvested at January 1, 202357,356 $228.33 
Granted20,705 225.34 
Vested(15,981)229.03 
Forfeited(3,420)208.02 
Unvested at September 30, 202358,660 $208.02 

Total compensation cost for cash-settled restricted stock is recorded in the Condensed Consolidated Statements of Income as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
Cost of sales$— $— $0.2 $— 
Selling, general and administrative expenses0.6 1.1 2.1 1.1 
Total expense before income taxes0.6 1.1 2.3 1.1 
Income tax benefit— — (0.1)— 
Total expense after income taxes$0.6 $1.1 $2.2 $1.1 

As of September 30, 2023, there was $4.8 million of total unrecognized compensation cost related to cash-settled restricted shares that is expected to be recognized over a weighted-average period of 1.1 years.

Performance Share Units

Weighted average performance share unit fair values and assumptions for the periods specified are disclosed below. The performance share units are market condition awards and have been assessed at fair value on the date of grant using a Monte Carlo simulation model.
 Nine Months Ended September 30,
20232022
Weighted average fair value of grants$308.18$235.54
Dividend yield—%—%
Volatility27.00%28.09%
Risk-free interest rate4.37%1.73%
Expected life (in years)2.942.93

A summary of the Company’s performance share unit activity as of September 30, 2023 and changes during the nine months ended September 30, 2023 are presented in the following table:
Performance Share UnitsSharesWeighted-Average
Grant Date Fair
Value
Unvested at January 1, 202370,915 $236.66 
Granted28,030 308.18 
Vested(18,105)226.86 
Forfeited(12,050)262.44 
Unvested at September 30, 202368,790 $265.22 

On January 31, 2023, 18,105 performance share units vested. Based on the Company’s relative total shareholder return rank during the three year period ended January 31, 2023, the Company achieved a 173% payout factor and issued 31,334 common shares in February 2023 for awards that vested in 2023.
Total compensation cost for performance share units is recorded in the Condensed Consolidated Statements of Income as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Cost of sales$— $— $— $— 
Selling, general and administrative expenses(1)
(0.3)0.2 5.7 4.0 
Total expense before income taxes(0.3)0.2 5.7 4.0 
Income tax benefit(0.1)— (0.3)(0.1)
Total expense after income taxes$(0.4)$0.2 $5.4 $3.9 

(1) The three months ended September 30, 2023 include $1.0 million of lower expense due to executive forfeitures, net of $0.4 million of higher expense due to timing of accelerated stock compensation costs for retiree eligible participants compared with the same period in 2022. The nine months ended September 30, 2023 include $2.0 million of higher expense as it relates to the timing of accelerated stock compensation costs for retiree eligible participants, net of $0.7 million of executive forfeitures when compared with the same period in 2022.

As of September 30, 2023, there was $3.1 million of total unrecognized compensation cost related to performance share units that is expected to be recognized over a weighted-average period of 1.1 years.